NLRP3 inflammasome in expressed prostatic secretions as a potential biomarker of chronic prostatitis/chronic pelvic pain syndrome
NLRP3 levels in EPS were significantly higher in NIH-IIIA and NIH-IIIB patients compared to BPH patients and healthy controls. NLRP3 inflammasome levels in EPS may be valuable as diagnostic indicators, and targeting chemokines may present a promising approach to treatment for those suffering from CPPS.
Authors
- Huadong Wang (ORCID: https://orcid.org/0000-0002-2197-3624)
- Yingnan Liu (ORCID: https://orcid.org/0009-0000-8784-0528)
- Chunyan Ma (ORCID: https://orcid.org/0009-0003-5154-8922)
Institutions
- Tianjin Medical University (CN)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2024-12-04
- DOI
- https://doi.org/10.17219/acem/192548
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00